Esomeprazole and omeprazole might boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects like drowsiness, although the clinical relevance is low in most patients – monitor the patient for adverse effects (e.If affected individual simply cannot resume their common oral medication publish-ope

Esomeprazole and omeprazole might enhance the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) leading to enhanced adverse effects such as drowsiness, although the clinical relevance is reduced in many sufferers – keep an eye on the client for adverse effects (e.If affected person cannot resume their standard oral medicati